Tranexamic acid may cut recovery time in breast augmentation
NCT ID NCT03364569
First seen Jun 10, 2026 · Last updated Jun 22, 2026 · Updated 2 times
Summary
This study tested whether taking tranexamic acid (TXA) before and after breast implant surgery reduces fluid drainage. Forty women having their first breast augmentation took TXA pills, and doctors measured how much fluid drained from the surgical site. The goal was to see if TXA could help patients heal faster and possibly leave the hospital sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASTIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital NOVO
Cergy-Pontoise, 95300, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tranexamic acid
What this could lead to
If it works, this could reduce post-surgical drainage and shorten recovery time for women undergoing breast augmentation.
What could go wrong
This is a small, completed study with only 40 participants. Results may not apply to all patients, and the benefit may be modest.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.